EGFR and cancer: Using publicly available chromatin binding data sets we observed binding of several transcriptional regulators which lie downstream of EGFR, KRAS, PI3K and EMT signalling pathways (Figure 3D), providing tangible leads for future functional studies aiming to decipher the regulators of MCT2 in cancer.